For fiscal year 2023, we now expect net sales in the range of $450,000,000 to 4 60,000,000 versus our previously reported range of $445,000,000 to 465,000,000 Adjusted EBITDA in the range of $166,000,000 to $174,000,000 compared to our previously reported range of $161,000,000 to $176,000,000 and adjusted net income in the range of $100,000,000 to $108,000,000 versus our previously reported range of $96,000,000 to $108,000,000 For the year, we assume adjusted gross margin in the range of 70.5% to 71%. In the medium term, we remain confident And we can return closer to our historical adjusted gross margin levels in the mid-seventy percent range. We continue to assume net interest expense to be approximately $40,000,000 and an adjusted effective tax rate of approximately 20% for the year. In conclusion, we believe the Q3 represented good progress against our goal to stabilize the demand trend in the second half of twenty twenty three and we're pleased to update the annual guidance range for this year. We continue to believe our company will once again achieve consistent profitable growth as we invest in foundational capabilities, Leverage our patented technology and powerful community of advocates and implement our strategic initiatives.